<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11422">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00575510</url>
  </required_header>
  <id_info>
    <org_study_id>05-245</org_study_id>
    <secondary_id>R01CA107015</secondary_id>
    <nct_id>NCT00575510</nct_id>
  </id_info>
  <brief_title>Intervention to Improve Follow-up of Abnormal Pap Test</brief_title>
  <official_title>Intervention to Improve Follow-up of Abnormal Pap Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will examine whether a theory-based telephone intervention delivered by a nurse
      at the time women are informed of an abnormal Pap test result will increase adherence to
      follow-up recommendations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over 90% of deaths due to cervical cancer could be prevented with appropriate screening and
      treatment of precursor lesions. However, 20% to 70% of women in the United States who are
      told that their Papanicolaou (Pap) test was abnormal do not adhere to recommendations for
      follow-up care. This is a problem especially among minorities and women of lower
      socioeconomic status. The purpose of this part of the protocol is to test a theory-based
      intervention designed to improve adherence to follow-up among women who experience an
      abnormal Pap test. The intervention is a message, delivered over the telephone by a nurse,
      at the time Pap test results are given to patients. The investigators propose to randomize
      women who experience an abnormal Pap test to one of three groups: (1) targeted cultural
      belief + knowledge + importance message (intervention), (2) nontargeted belief + knowledge +
      importance (active control), or (3) standard care only (passive control). All three groups
      will receive standard care, which is to notify women by telephone of their abnormal results
      and provide instructions for follow-up. Women assigned to the intervention group also will
      receive a cultural belief component consistent with their racial/ethnic group, detailed
      information about follow-up procedures and the consequences of not returning for follow-up,
      and information regarding the importance of adhering to recommendations, particularly for
      &quot;low grade&quot; abnormalities. Women assigned to the active control group will receive a
      nontargeted belief component, plus procedural knowledge and a message on the importance of
      follow-up. Adherence to initial follow-up will be the primary outcome. Other behavioral
      outcomes, such as delayed care and completeness of care, also will be assessed over an
      18-month interval by chart review. Additionally, the investigators will evaluate
      psychological outcomes including anxiety and distress. Finally, the investigators will
      examine the grade of abnormality (low versus high) as an effect modifier. The investigators
      anticipate that this research will result in an intervention that will improve several
      important behavioral and psychological outcomes related to abnormal Pap test results. The
      intervention is guided by a general integrative theoretical framework; therefore, this
      research will evaluate an intervention strategy that recognizes the importance of targeting
      culturally relevant beliefs about follow-up and key determinants of behavior
      (knowledge/skills, salience, environmental constraints) surrounding abnormal Pap test
      results. Ultimately, the objective of this research is to improve adherence to follow-up
      among low-income, minority women who are at particular risk of developing cervical cancer.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Adherence to Initial Follow-up (Yes/no)</measure>
    <time_frame>adherence rates at initial follow-up appointment, 2 weeks to 3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Attendance at initial appointment to follow-up abnormal Pap test result</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>State Trait Anxiety Inventory (STAI)-State Scale</measure>
    <time_frame>+ 7-30 days post-intervention</time_frame>
    <safety_issue>No</safety_issue>
    <description>State Anxiety short form measure (6-item); higher scores =worse outcomes (i.e., higher self-reported anxiety levels)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">341</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care Only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Clinical standard of care at time of study</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intervention</intervention_name>
    <description>Multiple component intervention based in the unified theory of behavior</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active control</intervention_name>
    <description>Partial intervention (full intervention minus cultural-specific component)</description>
    <arm_group_label>Active Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women aged 18 to 55 years who present to the University of Texas Medical Branch
             (UTMB) clinics for Pap testing.

        Exclusion Criteria:

          -  Women who are currently pregnant

          -  Have a current diagnosis of cervical cancer; or

          -  Who are unable to understand English or Spanish.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmen R Breitkopf, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Medical Branch, Galveston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Breitkopf CR, Dawson L, Grady JJ, Breitkopf DM, Nelson-Becker C, Snyder RR. Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial. Health Psychol. 2014 Apr;33(4):307-16. doi: 10.1037/a0032722. Epub 2013 Jun 3.</citation>
    <PMID>23730719</PMID>
  </results_reference>
  <verification_date>July 2014</verification_date>
  <lastchanged_date>July 28, 2014</lastchanged_date>
  <firstreceived_date>December 14, 2007</firstreceived_date>
  <firstreceived_results_date>May 19, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>unified theory of behavior</keyword>
  <keyword>Pap test</keyword>
  <keyword>cervical dysplasia</keyword>
  <keyword>women's health</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Face-to-face recruitment of women 18-55 years of age occurred in 6 University of Texas Medical Branch (UTMB) Regional and Maternal Child Health Program clinics from June 1, 2006-November 30, 2010. Recruitment was interrupted for a period ranging from 2 weeks to 6 months in several clinic sites due to landfall of hurricane Ike on September 13, 2008.</recruitment_details>
      <pre_assignment_details>6,179 women were eligible during the recruitment period. Of these, 876 declined participation, 4,671 had a normal Pap test result, 254 did not have a Pap test performed at their clinic visit, and 378 had an abnormal Pap test result and could be randomized. Of these, 90% (341/378)were randomized into the 3-arm trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling</description>
        </group>
        <group group_id="P2">
          <title>Active Control</title>
          <description>nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling</description>
        </group>
        <group group_id="P3">
          <title>Standard Care Only</title>
          <description>Clinical standard of care at time of study</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="114"/>
                <participants group_id="P2" count="114"/>
                <participants group_id="P3" count="113"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="102"/>
                <participants group_id="P2" count="101"/>
                <participants group_id="P3" count="96"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Clinic Called Patient</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling</description>
        </group>
        <group group_id="B2">
          <title>Active Control</title>
          <description>nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling</description>
        </group>
        <group group_id="B3">
          <title>Standard Care Only</title>
          <description>Clinical standard of care at time of study</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="114"/>
                <measurement group_id="B2" value="114"/>
                <measurement group_id="B3" value="113"/>
                <measurement group_id="B4" value="341"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="27" spread="7"/>
                <measurement group_id="B2" value="28" spread="8"/>
                <measurement group_id="B3" value="29" spread="8"/>
                <measurement group_id="B4" value="28" spread="7"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="114"/>
                <measurement group_id="B2" value="114"/>
                <measurement group_id="B3" value="113"/>
                <measurement group_id="B4" value="341"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="114"/>
                <measurement group_id="B2" value="114"/>
                <measurement group_id="B3" value="113"/>
                <measurement group_id="B4" value="341"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Adherence to Initial Follow-up (Yes/no)</title>
        <description>Attendance at initial appointment to follow-up abnormal Pap test result</description>
        <time_frame>adherence rates at initial follow-up appointment, 2 weeks to 3 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Intervention: Multiple component intervention based in the unified theory of behavior</description>
          </group>
          <group group_id="O2">
            <title>Active Control</title>
            <description>nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Active control: Partial intervention (full intervention minus cultural-specific component)</description>
          </group>
          <group group_id="O3">
            <title>Standard Care Only</title>
            <description>Clinical standard of care at time of study</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="102"/>
                  <measurement group_id="O2" value="101"/>
                  <measurement group_id="O3" value="96"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Adherence to Initial Follow-up (Yes/no)</title>
            <description>Attendance at initial appointment to follow-up abnormal Pap test result</description>
            <units>percentage of patients who were adherent</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="60"/>
                  <measurement group_id="O2" value="54"/>
                  <measurement group_id="O3" value="58"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>State Trait Anxiety Inventory (STAI)-State Scale</title>
        <description>State Anxiety short form measure (6-item); higher scores =worse outcomes (i.e., higher self-reported anxiety levels)</description>
        <time_frame>+ 7-30 days post-intervention</time_frame>
        <safety_issue>No</safety_issue>
        <population>Only participants who completed the post-test over the telephone 7-14 following notification of the abnormal Pap test result were asked these questions.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Intervention: Multiple component intervention based in the unified theory of behavior</description>
          </group>
          <group group_id="O2">
            <title>Active Control</title>
            <description>non-targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Active control: Partial intervention (full intervention minus cultural-specific component)</description>
          </group>
          <group group_id="O3">
            <title>Standard Care Only</title>
            <description>Clinical standard of care at time of study</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="77"/>
                  <measurement group_id="O2" value="76"/>
                  <measurement group_id="O3" value="74"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>State Trait Anxiety Inventory (STAI)-State Scale</title>
            <description>State Anxiety short form measure (6-item); higher scores =worse outcomes (i.e., higher self-reported anxiety levels)</description>
            <units>units on a scale, possible range 6-24</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="12" spread="5"/>
                  <measurement group_id="O2" value="11" spread="4"/>
                  <measurement group_id="O3" value="11" spread="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Culturally targeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Intervention: Multiple component intervention based in the unified theory of behavior</description>
        </group>
        <group group_id="E2">
          <title>Active Control</title>
          <description>nontargeted behavioral and normative beliefs + knowledge/skills + salience + environmental constraints/barriers counseling
Active control: Partial intervention (full intervention minus cultural-specific component)</description>
        </group>
        <group group_id="E3">
          <title>Standard Care Only</title>
          <description>Clinical standard of care at time of study</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="114"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="114"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="113"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="114"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="114"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="113"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Carmen Radecki Breitkopf</name_or_title>
      <organization>Mayo Clinic</organization>
      <phone>507-266-0969</phone>
      <email>radeckibreitkopf.carmen@mayo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
